Boiron SA (FRA:BON)

Market Cap	446.21M +9.4%
Revenue (ttm)	501.11M +4.8%
Net Income	32.64M -18.2%
EPS	1.88 -18.2%
Shares Out	n/a
PE Ratio	13.67
Forward PE	12.36
Dividend	1.35 (5.40%)
Ex-Dividend Date	Jun 3, 2026

Volume	n/a
Average Volume	22
Open	25.30
Previous Close	25.40
Day's Range	25.30 - 25.30
52-Week Range	20.65 - 31.35
Beta	n/a
RSI	44.27
Earnings Date	Jul 17, 2026

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for a...

• Industry: Pharmaceutical Preparations
• Founded: 1932
• Employees: 2,736
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: BON

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.